BusinessVBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 MillionBy Nasdaq OMXOct 26, 2017, 1:29 PM UTC
BusinessVBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common SharesBy Nasdaq OMXOct 25, 2017, 8:01 PM UTC
BusinessActinium Pharmaceuticals Announces Activation of Fifteenth Clinical Trial Site in the Phase 3 SIERRA Trial for Iomab-BBy Nasdaq OMXOct 25, 2017, 11:30 AM UTC
BusinessSignificant advance in breast cancer care – Cohera Medical, Inc. ® Drain-Free Mastectomy trial reaches full enrollmentBy Nasdaq OMXOct 17, 2017, 1:00 PM UTC
BusinessEarth Science Tech, Inc. Partners with Centre SIDA Amite Clinic to Commence Final Pre-Launch MSN-2 Human Research StudyBy Nasdaq OMXOct 10, 2017, 12:31 PM UTC
BusinessSummit Highlights Microbiome Preservation During Ridinilazole Treatment in Exploratory Phase 2 Clinical Trial at ID Week 2017By Nasdaq OMXOct 9, 2017, 11:00 AM UTC
BusinessSummit Announces Positive Top-Line Data From an Exploratory Phase 2 Clinical Trial Supporting Ridinilazole as a Highly Selective Antibiotic for the Treatment of CDIBy Nasdaq OMXSep 5, 2017, 11:01 AM UTC
BusinessMYnd Analytics Invited to Present Updated Data at Military Research SymposiumBy Nasdaq OMXAug 29, 2017, 11:30 AM UTC
